TW200718701A - Substituted pyrrolopyridines, compositions containing same, manufacturing process therefor and use thereof - Google Patents
Substituted pyrrolopyridines, compositions containing same, manufacturing process therefor and use thereofInfo
- Publication number
- TW200718701A TW200718701A TW095114907A TW95114907A TW200718701A TW 200718701 A TW200718701 A TW 200718701A TW 095114907 A TW095114907 A TW 095114907A TW 95114907 A TW95114907 A TW 95114907A TW 200718701 A TW200718701 A TW 200718701A
- Authority
- TW
- Taiwan
- Prior art keywords
- compositions containing
- manufacturing process
- containing same
- process therefor
- substituted pyrrolopyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0504173A FR2884821B1 (fr) | 2005-04-26 | 2005-04-26 | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200718701A true TW200718701A (en) | 2007-05-16 |
Family
ID=35517344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095114907A TW200718701A (en) | 2005-04-26 | 2006-04-26 | Substituted pyrrolopyridines, compositions containing same, manufacturing process therefor and use thereof |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7947706B2 (zh) |
| EP (1) | EP1877409B1 (zh) |
| JP (1) | JP2008539211A (zh) |
| KR (1) | KR20080007229A (zh) |
| CN (1) | CN101166739A (zh) |
| AR (1) | AR061386A1 (zh) |
| AT (1) | ATE433976T1 (zh) |
| AU (1) | AU2006239105A1 (zh) |
| BR (1) | BRPI0613161A2 (zh) |
| CA (1) | CA2605744A1 (zh) |
| CR (1) | CR9463A (zh) |
| CY (1) | CY1109369T1 (zh) |
| DE (1) | DE602006007337D1 (zh) |
| DK (1) | DK1877409T3 (zh) |
| DO (1) | DOP2006000096A (zh) |
| EA (1) | EA012983B1 (zh) |
| ES (1) | ES2328629T3 (zh) |
| FR (1) | FR2884821B1 (zh) |
| GT (1) | GT200600174A (zh) |
| HR (1) | HRP20090494T1 (zh) |
| IL (1) | IL186523A0 (zh) |
| MA (1) | MA29480B1 (zh) |
| MX (1) | MX2007013084A (zh) |
| NO (1) | NO20075918L (zh) |
| PA (1) | PA8671301A1 (zh) |
| PE (1) | PE20071420A1 (zh) |
| PL (1) | PL1877409T3 (zh) |
| PT (1) | PT1877409E (zh) |
| RS (1) | RS51136B (zh) |
| SI (1) | SI1877409T1 (zh) |
| TN (1) | TNSN07360A1 (zh) |
| TW (1) | TW200718701A (zh) |
| WO (1) | WO2006114520A2 (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| GEP20135728B (en) * | 2006-10-09 | 2013-01-25 | Takeda Pharmaceuticals Co | Kinase inhibitors |
| EP2223925A1 (en) * | 2006-10-09 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| CN101679409B (zh) | 2006-12-22 | 2014-11-26 | Astex治疗学有限公司 | 双环杂环衍生化合物、其医药组合物和其用途 |
| CA2672172C (en) * | 2006-12-22 | 2016-05-03 | Astex Therapeutics Limited | Bicyclic heterocyclic compounds as fgfr inhibitors |
| WO2009012283A1 (en) | 2007-07-17 | 2009-01-22 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
| GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
| GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
| DE102008052943A1 (de) | 2008-10-23 | 2010-04-29 | Merck Patent Gmbh | Azaindolderivate |
| SG173178A1 (en) | 2009-04-03 | 2011-09-29 | Hoffmann La Roche | Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
| GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| US20110030037A1 (en) * | 2009-07-07 | 2011-02-03 | Vadim Olshansky | Zone migration in network access |
| US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
| NZ629615A (en) | 2009-11-06 | 2016-01-29 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| EA028821B9 (ru) | 2011-02-07 | 2018-10-31 | Плексксикон, Инк. | Соединения и способы для модуляции киназ, а также показания к их применению |
| TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
| EP2855477A4 (en) * | 2012-05-29 | 2015-11-18 | Merck Sharp & Dohme | BARYARY COMPOUNDS, ISOTOPICALLY MARKED |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| GB201310460D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
| GB201310464D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3254843B2 (ja) * | 1993-08-09 | 2002-02-12 | 三菱ウェルファーマ株式会社 | 新規縮合ヘテロ環誘導体 |
| US6335342B1 (en) * | 2000-06-19 | 2002-01-01 | Pharmacia & Upjohn S.P.A. | Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| GB0115109D0 (en) * | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| US7427623B2 (en) * | 2001-09-11 | 2008-09-23 | Smithkline Beecham Corporation | 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| WO2003028724A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
| CA2464214C (en) * | 2001-10-22 | 2011-02-08 | The Research Foundation Of State University Of New York | Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| KR20040111445A (ko) * | 2002-03-28 | 2004-12-31 | 에자이 가부시키가이샤 | 신경퇴행성 질환 치료용 ｃ─Ｊｕｎ Ｎ─말단 키나아제억제제로서의 ７─아자인돌 |
| FR2878849B1 (fr) * | 2004-12-06 | 2008-09-12 | Aventis Pharma Sa | Indoles substitues, compositions les contenant, procede de fabrication et utilisation |
-
2005
- 2005-04-26 FR FR0504173A patent/FR2884821B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-25 AR ARP060101646A patent/AR061386A1/es unknown
- 2006-04-25 PE PE2006000435A patent/PE20071420A1/es not_active Application Discontinuation
- 2006-04-26 PL PL06743743T patent/PL1877409T3/pl unknown
- 2006-04-26 DE DE602006007337T patent/DE602006007337D1/de active Active
- 2006-04-26 AT AT06743743T patent/ATE433976T1/de active
- 2006-04-26 PT PT06743743T patent/PT1877409E/pt unknown
- 2006-04-26 EA EA200702329A patent/EA012983B1/ru not_active IP Right Cessation
- 2006-04-26 JP JP2008508258A patent/JP2008539211A/ja active Pending
- 2006-04-26 KR KR1020077024847A patent/KR20080007229A/ko not_active Application Discontinuation
- 2006-04-26 PA PA20068671301A patent/PA8671301A1/es unknown
- 2006-04-26 MX MX2007013084A patent/MX2007013084A/es active IP Right Grant
- 2006-04-26 DK DK06743743T patent/DK1877409T3/da active
- 2006-04-26 TW TW095114907A patent/TW200718701A/zh unknown
- 2006-04-26 CN CNA200680014034XA patent/CN101166739A/zh active Pending
- 2006-04-26 CA CA002605744A patent/CA2605744A1/fr not_active Abandoned
- 2006-04-26 AU AU2006239105A patent/AU2006239105A1/en not_active Withdrawn
- 2006-04-26 GT GT200600174A patent/GT200600174A/es unknown
- 2006-04-26 BR BRPI0613161-1A patent/BRPI0613161A2/pt not_active IP Right Cessation
- 2006-04-26 EP EP06743743A patent/EP1877409B1/fr active Active
- 2006-04-26 WO PCT/FR2006/000925 patent/WO2006114520A2/fr active Application Filing
- 2006-04-26 ES ES06743743T patent/ES2328629T3/es active Active
- 2006-04-26 DO DO2006000096A patent/DOP2006000096A/es unknown
- 2006-04-26 SI SI200630396T patent/SI1877409T1/sl unknown
- 2006-04-26 RS RSP-2009/0400A patent/RS51136B/sr unknown
-
2007
- 2007-09-21 TN TNP2007000360A patent/TNSN07360A1/en unknown
- 2007-10-09 IL IL186523A patent/IL186523A0/en unknown
- 2007-10-11 US US11/870,640 patent/US7947706B2/en not_active Expired - Fee Related
- 2007-10-22 CR CR9463A patent/CR9463A/es not_active Application Discontinuation
- 2007-11-16 NO NO20075918A patent/NO20075918L/no not_active Application Discontinuation
- 2007-11-22 MA MA30412A patent/MA29480B1/fr unknown
-
2009
- 2009-09-16 HR HR20090494T patent/HRP20090494T1/hr unknown
- 2009-09-16 CY CY20091100957T patent/CY1109369T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200718701A (en) | Substituted pyrrolopyridines, compositions containing same, manufacturing process therefor and use thereof | |
| TW200639173A (en) | Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof | |
| TW200800999A (en) | Novel compounds | |
| TW200745103A (en) | Substituted 7-azaindazoles, compositions containing them, production process and use | |
| TW200640857A (en) | Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof | |
| TW200634007A (en) | Substituted indoles, compositions containing them, production process and use | |
| TW200745114A (en) | Novel compounds | |
| TW200732340A (en) | Novel forms of tiotropium bromide and processes for preparation thereof | |
| TW200616995A (en) | Novel compounds | |
| TW200745084A (en) | Novel compounds | |
| TW200626593A (en) | Novel compounds | |
| TW200801003A (en) | Novel compounds | |
| MX2013001069A (es) | Derivados anticancer, preparacion de los mismos y su uso terapeutico. | |
| TW200630343A (en) | 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
| TW200738659A (en) | Novel compounds | |
| TNSN08321A1 (en) | Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof | |
| TW200726758A (en) | New pyridine analogues | |
| TW200718698A (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
| MX2010009927A (es) | Derivados de espiroindolinona. | |
| DOP2006000015A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación | |
| MX2009000768A (es) | Lactamas macrociclicas. | |
| TW200640858A (en) | Substituted pyrroles, compositions containing them, method of manufacture and use | |
| GB0615105D0 (en) | Novel compounds | |
| TW200633717A (en) | Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
| EA200870567A1 (ru) | Производные 2-алкокси-3,4,5-тригидроксиалкиламида, их получение, композиции, их содержащие, и применение |